Kubota Pharmaceutical Holdings Co., Ltd. Stock: price and insider trades · Japan
窪田製薬ホールディングス株式会社
No insider purchase over the last 90 days. The latest, by バークレイズ・キャピタル・セキュリティーズ・リミテッド(Barclays Capital Securities Ltd.), was filed 14 Nov 2022.
Kubota Pharmaceutical Holdings Co., Ltd.: what insiders have been doing
Every trade that managers of Kubota Pharmaceutical Holdings Co., Ltd. disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. In the past year (1 November 2025 to 1 November 2026), 25 filings came from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (3,213 companies, median 3 filings), a count of 25 filings is above the norm. Our records for Kubota Pharmaceutical Holdings Co., Ltd. go back to 2022, with 312 purchases and 348 sales on the open market in total.
Insider buying of Kubota Pharmaceutical Holdings Co., Ltd. has been absent for the past year. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -43.8%Entry JP¥128 · Close at T+365 JP¥72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 33.9% of flowShareXTKSEDINET:S100YQ8Q
- 8.3% of flowShareXTKSEDINET:S100YPAP
- 9.6% of flowShareXTKSEDINET:S100YOWO
- 11.1% of flowShareXTKSEDINET:S100YO6D
- 1.0% of flowShareXTKSEDINET:S100YGCL
- 0.7% of flowShareXTKSEDINET:S100Y9UB
- 1.1% of flowShareXTKSEDINET:S100Y7R6
- 0.0% of flowShareXTKSEDINET:S100Y1SO
- 0.0% of flowShareXTKSEDINET:S100Y0HF
- 0.0% of flowShareXTKSEDINET:S100XYUV
- 2.1% of flowShareXTKSEDINET:S100XWZM
- 3.5% of flowShareXTKSEDINET:S100XULC
- 3.1% of flowShareXTKSEDINET:S100XSY4
- 3.5% of flowShareXTKSEDINET:S100XRF7
- 7.6% of flowShareXTKSEDINET:S100XQWP
- 10.2% of flowShareXTKSEDINET:S100XQ3Y
- 3.5% of flowShareXTKSEDINET:S100XPWG
- 0.8% of flowShareXTKSEDINET:S100XPLJ
- 0.0% of flowShareXTKSEDINET:S100XPC1
- 0.0% of flowShareXTKSEDINET:S100XOU0
- 0.0% of flowShareXTKSEDINET:S100XF64
- 0.0% of flowShareXTKSEDINET:S100XEO0
- 0.0% of flowShareXTKSEDINET:S100XDPE
- 29.5% of flowShareXTKSEDINET:S100XCN4
- 42.4% of flowShareXTKSEDINET:S100XC52
25 of 734 declarations
About Kubota Pharmaceutical Holdings Co., Ltd.
Kubota Pharmaceutical Holdings Co., Ltd. is a Japanese company focused on the health and pharmaceutical sector. It specializes in the development of innovative treatments and therapeutic solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
